Deletion of p53 in cancer cells increases ROS levels, activates STAT3 signaling, and regulates the expression of inflammatory cytokines including monocyte chemoattractant protein-1 (MCP-1), interleukin 6 (IL6), and colony-stimulating factor 1 (CSF1) [17]. Here, CCL2 is linked to cancer.